Cross Neutralization | List of Frontiers open access articles

Original Research

Published on 15 Sep 2023

Immunogenic epitope scanning in bacteriolytic enzymes Pal and Cpl-1 and engineering Pal to escape antibody responses

in Vaccines and Molecular Therapeutics

Marek Adam Harhala
Katarzyna Gembara
Izabela Rybicka
Zuzanna Maria Kaźmierczak
Paulina Miernikiewicz
Joanna Marta Majewska
Wiktoria Budziar
Anna Nasulewicz-Goldeman
Daniel C. Nelson
Barbara Owczarek

Frontiers in Immunology

doi 10.3389/fimmu.2023.1075774

3,553 views
4 citations

Original Research

Published on 16 Jul 2025

Cross-neutralization ability of anti-MERS-CoV monoclonal antibodies against a variety of merbecoviruses

in Virology

Lin Pan
Yu Kaku
Jarel Elgin Tolentino
Yusuke Kosugi
Kei Sato

Frontiers in Microbiology

doi 10.3389/fmicb.2025.1593095

3,633 views

Original Research

Published on 08 Aug 2023

Classification of genotypes based on the VP1 gene of feline calicivirus and study of cross-protection between different genotypes

in Virology

Yupeng Yang
Zhe Liu
Mengru Chen
Kexin Feng
Ruibin Qi
Yating Zheng
Ying Wang
Hongtao Kang
Qian Jiang
Mingfa Yang

Frontiers in Microbiology

doi 10.3389/fmicb.2023.1226877

5,675 views
18 citations

Original Research

Published on 27 Apr 2023

Cross-reactivities and cross-neutralization of different envelope glycoproteins E2 antibodies against different genotypes of classical swine fever virus

in Veterinary Infectious Diseases

Wei-Tao Chen
Hsin-Meng Liu
Chia-Yi Chang
Ming-Chung Deng
Yu-Liang Huang
Yen-Chen Chang
Hui-Wen Chang

Frontiers in Veterinary Science

doi 10.3389/fvets.2023.1169766

3,547 views
2 citations

Original Research

Published on 17 Aug 2021

Crucial Mutations of Spike Protein on SARS-CoV-2 Evolved to Variant Strains Escaping Neutralization of Convalescent Plasmas and RBD-Specific Monoclonal Antibodies

in Viral Immunology

Chengchao Ding
Jun He
Xiangyu Zhang
Chengcheng Jiang
Yong Sun
Yuqing Zhang
Qingqing Chen
Hongliang He
Wenting Li
Jiajia Xie

Frontiers in Immunology

doi 10.3389/fimmu.2021.693775

9,300 views
44 citations

Original Research

Published on 17 May 2022

Long-Lived Immunity in SARS-CoV-2-Recovered Children and Its Neutralizing Capacity Against Omicron

in Mucosal Immunity

Justyna Sieber
Margareta Mayer
Klara Schmidthaler
Sonja Kopanja
Jeremy V. Camp
Amelie Popovitsch
Varsha Dwivedi
Jakub Hoz
Anja Schoof
Lukas Weseslindtner

Frontiers in Immunology

doi 10.3389/fimmu.2022.882456

4,666 views
19 citations

Brief Research Report

Published on 10 Jun 2022

The Cross-Protective Immunity Landscape Among Different SARS-CoV-2 Variant RBDs

in Vaccines and Molecular Therapeutics

Wenqiang Sun
Lihong He
Huicong Lou
Wenhui Fan
Limin Yang
Gong Cheng
Wenjun Liu
Lei Sun

Frontiers in Immunology

doi 10.3389/fimmu.2022.898520

3,622 views
4 citations

Original Research

Published on 31 Jul 2020

Leveraging a Validated in silico Approach to Elucidate Genotype-Specific VP7 Epitopes and Antigenic Relationships of Porcine Rotavirus A

in Computational Genomics

Frances K. Shepherd
Cheryl M. T. Dvorak
Michael P. Murtaugh
Douglas G. Marthaler

Frontiers in Genetics

doi 10.3389/fgene.2020.00828

4,208 views
5 citations

Review

Published on 27 Sep 2021

Broadly-Neutralizing Antibodies Against Emerging SARS-CoV-2 Variants

in Viral Immunology

Lok Bahadur Shrestha
Nicodemus Tedla
Rowena A. Bull

Frontiers in Immunology

doi 10.3389/fimmu.2021.752003

21,301 views
84 citations

Original Research

Published on 23 Nov 2021

Studies on Growth Characteristics and Cross-Neutralization of Wild-Type and Delta SARS-CoV-2 From Hisar (India)

in Clinical and Diagnostic Microbiology and Immunology

Nitin Khandelwal
Yogesh Chander
Ram Kumar
Himanshu Nagori
Assim Verma
Priyasi Mittal
Riyesh T
Sameer Kamboj
Sukhbir Singh Verma
Subhash Khatreja

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2021.771524

9,077 views
10 citations

Original Research

Published on 08 Nov 2023

Advances on two serological assays for human papillomavirus provide insights on the reactivity of antibodies against a cross-neutralization epitope of the minor capsid protein L2

in Vaccines and Molecular Therapeutics

Filipe Colaco Mariz
Kerstin Putzker
Peter Sehr
Martin Müller

Frontiers in Immunology

doi 10.3389/fimmu.2023.1272018

3,145 views
2 citations

Brief Research Report

Published on 28 Apr 2023

Host immune responses in aged rhesus macaques against BBV152, an inactivated SARS-CoV-2 vaccine, and cross-neutralization with beta and delta variants

in Vaccines and Molecular Therapeutics

Dilip R. Patil
Anita M. Shete
Pragya D. Yadav
Gajanan N. Sapkal
Gururaj R. Deshpande
Himanshu Kaushal
Sreelekshmy Mohandas
Siddharam Fulari
Rajlaxmi Jain
Ajay Kumar

Frontiers in Immunology

doi 10.3389/fimmu.2023.1161571

3,219 views
1 citation

Original Research

Published on 06 May 2024

Sero-epidemiological investigation and cross-neutralization activity against SARS-CoV-2 variants in cats and dogs, Thailand

in Veterinary Epidemiology and Economics

Sarin Suwanpakdee
Natthaphat Ketchim
Metawee Thongdee
Somjit Chaiwattanarungruengpaisan
Siriporn Tangsudjai
Witthawat Wiriyarat
Pruksa Julapanthong
Wachira Trakoolchaisri
Supakit Buamas
Walasinee Sakcamduang

Frontiers in Veterinary Science

doi 10.3389/fvets.2024.1329656

2,629 views
1 citation

Original Research

Published on 29 Mar 2023

Protection from successive Omicron variants with SARS-CoV-2 vaccine and monoclonal antibodies in kidney transplant recipients

in Infectious Agents and Disease

Valérie Moal
Margaux Valade
Céline Boschi
Thomas Robert
Nicolas Orain
Audrey Bancod
Sophie Edouard
Philippe Colson
Bernard La Scola

Frontiers in Microbiology

doi 10.3389/fmicb.2023.1147455

2,547 views
4 citations

Clinical Trial

Published on 01 Aug 2023

Safety and immunogenicity of rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine against SARS-CoV-2 in healthy adolescents: an open-label, non-randomized, multicenter, phase 1/2, dose-escalation study

in Vaccines and Molecular Therapeutics

Amir I. Tukhvatulin
Inna V. Dolzhikova
Alina S. Dzharullaeva
Daria M. Grousova
Anna V. Kovyrshina
Olga V. Zubkova
Ilya D. Zorkov
Anna A. Iliukhina
Artem Y. Shelkov
Alina S. Erokhova

Frontiers in Immunology

doi 10.3389/fimmu.2023.1228461

4,161 views
7 citations

Original Research

Published on 02 May 2023

A self-binding immune complex vaccine elicits strong neutralizing responses against herpes simplex virus in mice

in Vaccines and Molecular Therapeutics

Andrew G. Diamos
Mary D. Pardhe
Melissa H. Bergeman
Aigerim S. Kamzina
Michelle P. DiPalma
Sara Aman
Artemio Chaves
Kenneth Lowe
Jacquelyn Kilbourne
Ian B. Hogue

Frontiers in Immunology

doi 10.3389/fimmu.2023.1085911

5,546 views
1 citation

Articles

Immunogenic epitope scanning in bacteriolytic enzymes Pal and Cpl-1 and engineering Pal to escape antibody responses

Cross-neutralization ability of anti-MERS-CoV monoclonal antibodies against a variety of merbecoviruses

Classification of genotypes based on the VP1 gene of feline calicivirus and study of cross-protection between different genotypes

Cross-reactivities and cross-neutralization of different envelope glycoproteins E2 antibodies against different genotypes of classical swine fever virus

Crucial Mutations of Spike Protein on SARS-CoV-2 Evolved to Variant Strains Escaping Neutralization of Convalescent Plasmas and RBD-Specific Monoclonal Antibodies

Long-Lived Immunity in SARS-CoV-2-Recovered Children and Its Neutralizing Capacity Against Omicron

The Cross-Protective Immunity Landscape Among Different SARS-CoV-2 Variant RBDs

Leveraging a Validated in silico Approach to Elucidate Genotype-Specific VP7 Epitopes and Antigenic Relationships of Porcine Rotavirus A

Broadly-Neutralizing Antibodies Against Emerging SARS-CoV-2 Variants

Studies on Growth Characteristics and Cross-Neutralization of Wild-Type and Delta SARS-CoV-2 From Hisar (India)

Advances on two serological assays for human papillomavirus provide insights on the reactivity of antibodies against a cross-neutralization epitope of the minor capsid protein L2

Host immune responses in aged rhesus macaques against BBV152, an inactivated SARS-CoV-2 vaccine, and cross-neutralization with beta and delta variants

Sero-epidemiological investigation and cross-neutralization activity against SARS-CoV-2 variants in cats and dogs, Thailand

Protection from successive Omicron variants with SARS-CoV-2 vaccine and monoclonal antibodies in kidney transplant recipients

Safety and immunogenicity of rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine against SARS-CoV-2 in healthy adolescents: an open-label, non-randomized, multicenter, phase 1/2, dose-escalation study

A self-binding immune complex vaccine elicits strong neutralizing responses against herpes simplex virus in mice